About 2-bromoethanamine;3-bromo-6-(4-fluorophenyl)-5-(4-methylquinazolin-6-yl)pyridin-2-amine;3-[1-[2-(dimethylamino)ethyl]pyrazol-4-yl]-6-(4-fluorophenyl)-5-(4-methylquinazolin-6-yl)pyridin-2-amine;N,N-dimethyl-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethanamine;methane;4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole;hydrobromide
2-bromoethanamine;3-bromo-6-(4-fluorophenyl)-5-(4-methylquinazolin-6-yl)pyridin-2-amine;3-[1-[2-(dimethylamino)ethyl]pyrazol-4-yl]-6-(4-fluorophenyl)-5-(4-methylquinazolin-6-yl)pyridin-2-amine;N,N-dimethyl-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethanamine;methane;4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole;hydrobromide (PubChem CID 163925393) has the molecular formula C73H94B2Br3F2N17O4
and a molecular weight of 1573.00 g/mol. Its IUPAC name is 2-bromoethanamine;3-bromo-6-(4-fluorophenyl)-5-(4-methylquinazolin-6-yl)pyridin-2-amine;3-[1-[2-(dimethylamino)ethyl]pyrazol-4-yl]-6-(4-fluorophenyl)-5-(4-methylquinazolin-6-yl)pyridin-2-amine;N,N-dimethyl-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethanamine;methane;4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole;hydrobromide.
Frequently Asked Questions
What is the IUPAC name of 2-bromoethanamine;3-bromo-6-(4-fluorophenyl)-5-(4-methylquinazolin-6-yl)pyridin-2-amine;3-[1-[2-(dimethylamino)ethyl]pyrazol-4-yl]-6-(4-fluorophenyl)-5-(4-methylquinazolin-6-yl)pyridin-2-amine;N,N-dimethyl-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethanamine;methane;4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole;hydrobromide?
The IUPAC name of 2-bromoethanamine;3-bromo-6-(4-fluorophenyl)-5-(4-methylquinazolin-6-yl)pyridin-2-amine;3-[1-[2-(dimethylamino)ethyl]pyrazol-4-yl]-6-(4-fluorophenyl)-5-(4-methylquinazolin-6-yl)pyridin-2-amine;N,N-dimethyl-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethanamine;methane;4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole;hydrobromide (CID 163925393) is 2-bromoethanamine;3-bromo-6-(4-fluorophenyl)-5-(4-methylquinazolin-6-yl)pyridin-2-amine;3-[1-[2-(dimethylamino)ethyl]pyrazol-4-yl]-6-(4-fluorophenyl)-5-(4-methylquinazolin-6-yl)pyridin-2-amine;N,N-dimethyl-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethanamine;methane;4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole;hydrobromide.
What is the SMILES notation for 2-bromoethanamine;3-bromo-6-(4-fluorophenyl)-5-(4-methylquinazolin-6-yl)pyridin-2-amine;3-[1-[2-(dimethylamino)ethyl]pyrazol-4-yl]-6-(4-fluorophenyl)-5-(4-methylquinazolin-6-yl)pyridin-2-amine;N,N-dimethyl-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethanamine;methane;4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole;hydrobromide?
The canonical SMILES for 2-bromoethanamine;3-bromo-6-(4-fluorophenyl)-5-(4-methylquinazolin-6-yl)pyridin-2-amine;3-[1-[2-(dimethylamino)ethyl]pyrazol-4-yl]-6-(4-fluorophenyl)-5-(4-methylquinazolin-6-yl)pyridin-2-amine;N,N-dimethyl-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethanamine;methane;4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole;hydrobromide is Br.C.C.CC1(C)OB(c2cn[nH]c2)OC1(C)C.CN(C)CCn1cc(B2OC(C)(C)C(C)(C)O2)cn1.Cc1ncnc2ccc(-c3cc(-c4cnn(CCN(C)C)c4)c(N)nc3-c3ccc(F)cc3)cc12.Cc1ncnc2ccc(-c3cc(Br)c(N)nc3-c3ccc(F)cc3)cc12.NCCBr.
What is the InChIKey of 2-bromoethanamine;3-bromo-6-(4-fluorophenyl)-5-(4-methylquinazolin-6-yl)pyridin-2-amine;3-[1-[2-(dimethylamino)ethyl]pyrazol-4-yl]-6-(4-fluorophenyl)-5-(4-methylquinazolin-6-yl)pyridin-2-amine;N,N-dimethyl-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethanamine;methane;4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole;hydrobromide?
The InChIKey is AWASOGQJXSPCAA-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H26FN7.C20H14BrFN4.C13H24BN3O2.C9H15BN2O2.C2H6BrN.2CH4.BrH/c1-17-22-12-19(6-9-25(22)31-16-30-17)23-13-24(20-14-32-35(15-20)11-10-34(2)3)27(29)33-26(23)18-4-7-21(28)8-5-18;1-11-15-8-13(4-7-18(15)25-10-24-11)16-9-17(21)20(23)26-19(16)12-2-5-14(22)6-3-12;1-12(2)13(3,4)19-14(18-12)11-9-15-17(10-11)8-7-16(5)6;1-8(2)9(3,4)14-10(13-8)7-5-11-12-6-7;3-1-2-4;;;/h4-9,12-16H,10-11H2,1-3H3,(H2,29,33);2-10H,1H3,(H2,23,26);9-10H,7-8H2,1-6H3;5-6H,1-4H3,(H,11,12);1-2,4H2;2*1H4;1H.
What are the key properties of 2-bromoethanamine;3-bromo-6-(4-fluorophenyl)-5-(4-methylquinazolin-6-yl)pyridin-2-amine;3-[1-[2-(dimethylamino)ethyl]pyrazol-4-yl]-6-(4-fluorophenyl)-5-(4-methylquinazolin-6-yl)pyridin-2-amine;N,N-dimethyl-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethanamine;methane;4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole;hydrobromide?
2-bromoethanamine;3-bromo-6-(4-fluorophenyl)-5-(4-methylquinazolin-6-yl)pyridin-2-amine;3-[1-[2-(dimethylamino)ethyl]pyrazol-4-yl]-6-(4-fluorophenyl)-5-(4-methylquinazolin-6-yl)pyridin-2-amine;N,N-dimethyl-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethanamine;methane;4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole;hydrobromide has a molecular weight of 1573.00 g/mol, XLogP of 13.61, 14 rotatable bonds, 4 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for 2-bromoethanamine;3-bromo-6-(4-fluorophenyl)-5-(4-methylquinazolin-6-yl)pyridin-2-amine;3-[1-[2-(dimethylamino)ethyl]pyrazol-4-yl]-6-(4-fluorophenyl)-5-(4-methylquinazolin-6-yl)pyridin-2-amine;N,N-dimethyl-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethanamine;methane;4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole;hydrobromide is sourced from PubChem (CID 163925393), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).